Annonces et évènements

FierceBiotech

4 septembre 2018

Abivax posts ulcerative colitis data, commits to phase 2b

MarketWatch

4 septembre 2018

Abivax stock surges 9% on trial results for ulcerative colitis therapy

BioSpace

4 septembre 2018

Abivax Bolstered by Positive Mid-Stage Results from Ulcerative Colitis Treatment

Drug Development Technology

20 juillet 2018

Abivax completes dosing in ABX464-101 trial for UC

Draining HIV Viral Reservoirs: Abivax Prepares ABX464 Cure For Phase IIb

5 juillet 2018

Draining HIV Viral Reservoirs: Abivax Prepares ABX464 Cure For Phase IIb

1
2
3